Public Profile

Cardax, Inc.

Cardax, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States and operates across various regions. Founded in 2010, the company has made significant strides in developing innovative health solutions, particularly in the field of dietary supplements and pharmaceuticals. Specialising in the research and development of astaxanthin-based products, Cardax offers unique formulations that harness the antioxidant properties of this powerful carotenoid. Their flagship product, Zanthin®, stands out for its potential health benefits, including anti-inflammatory and neuroprotective effects. With a commitment to scientific excellence, Cardax has positioned itself as a leader in the nutraceutical market, achieving notable milestones in product development and regulatory approvals. The company continues to advance its mission of improving health outcomes through cutting-edge research and high-quality products.

DitchCarbon Score

How does Cardax, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

13

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Cardax, Inc.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.

58%

Cardax, Inc.'s reported carbon emissions

Cardax, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely aware of the growing importance of climate commitments in the industry and may be exploring initiatives to address carbon emissions and sustainability. As the landscape of corporate climate responsibility evolves, Cardax, Inc. may consider establishing measurable targets and strategies to align with industry standards and contribute to global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Cardax, Inc.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Cardax, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Cardax, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Taking Reduction Action?

Similar Organizations

Astellas

JP
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Bms

US
Chemicals nec
Updated 2 days ago

Laboratoires Servier

FR
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

Genentech

US
Research and development services (73)
Updated 13 days ago

Sanofi

FR
Chemicals nec
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers